Skip to content

Dr. Karim Baraké

Active
Private limited companyfounded 20233 years activeWezerenstraat 245A, 3401 Landen, BelgiumKBO/BCE: BE 1000.697.332
Summary

Dr. Karim Baraké has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €191,771 and a net result of €129,186. Its solvency ranks better than 78% of 20,374 sector peers (NACE 86, fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Overview

Activity
General medical practice
NACE 86210
2 sites
Size
€222,943total assets 2025
Equity
€191,771
Profit
€129,186
Turnover not published (abridged schema)
Financial health
98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Accounts 1 day early0 of 1 deed read
Why 98- Founded in 2023+ Sector Human health activities (NACE 86)+ Liquidity: current ratio 6.44, cash €193,313+ Equity €191,771 (86.0% of total assets)Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 86% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 100+9
equity 86.0% of total assets
Liquidity 98+13
short-term debt 14.0% · cash 86.7%
Profitability 100=
return on assets 57.9%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (23,979 companies)
Last 24 months 11-2024: 0.4% 12-2024: 0.4%● unchanged vs 11-2024 01-2025: 0.4%● unchanged vs 12-2024highest value 02-2025: 0.4%● unchanged vs 01-2025highest value 03-2025: < 0.1%▼ -0.4 percentage points vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit up to €18,000 at 30 days acceptable
Liquidity ample (current ratio 6.44 against 2.96 in 2024; short-term debt: 14% and cash: 86.7% of total assets), and 14% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 86% on liquidity, 80% on profitability and 95% on growth.

The bankruptcy probability was computed on 07-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals.
−lowers risk+raises risk○neutral
lowers risk · Sector Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 6.44, cash €193,313
NBB · annual accounts
lowers risk · Equity €191,771 (86.0% of total assets)
NBB · annual accounts
raises risk · Founded in 2023
How long the company has existed counts in the probability; how much depends on the rest of its profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 30-01-2026, 1 day ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
1 day early
2024
5 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 2 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
30-06-2026 close07-10-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Liquidity doublescurrent ratio 6.44
  3. Equity above €150,000Eq €191,771 ▲206%

Key points

  • Positive: Result rose in 2025from €59,585 to €129,186 ▲ 117% View
  • Total assets 20252 fiscal years filed €222,943 View
  • Active since 2023founded 03-10-2023 3 years View

By topic

Financials

Fiscal year
2025
Total assets
€222,943
Profit
€129,186
Solvency
86.0%
Total assets▲ 136%
Net result
20242025
Go to Financials

Timeline

Events
4
Since
2025
Next accounts
by 31-01-2027
  1. 05-02-2025Annual accounts filed
Go to Timeline

Company details

Sites
2
Legal form
Private limited company
Activity
General medical practiceNACE 86210
Founded
03-10-2023
Year ends
30-06
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.